Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer

被引：0

作者：

Ylstra, B. ^{[1
]}

Cordes, M. ^{[1
]}

Biesma, H. D. ^{[1
]}

Verheul, H. M. ^{[2
]}

Neerincx, M. ^{[2
]}

Koopman, M. ^{[3
]}

Punt, C. J. ^{[4
]}

Meijers, G. A. ^{[5
]}

Murphy, V. ^{[6
]}

Barat, A. ^{[7
]}

Betge, J. ^{[8
]}

Ebert, M. ^{[8
]}

Gaiser, T. ^{[8
]}

Fender, B. ^{[9
]}

Klinger, R. ^{[10
]}

Das, S. ^{[7
]}

Smeets, D. ^{[11
]}

Lambrechts, D. ^{[11
]}

Byrne, A. T. ^{[7
]}

Van Grieken, N. C. T. ^{[1
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Pathol, Amsterdam, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Oncol, Amsterdam, Netherlands

[3] Univ Med Ctr Utrecht, Dept Oncol, Amsterdam, Netherlands

[4] Univ Amsterdam, Acad Med Ctr, Dept Oncol, Amsterdam, Netherlands

[5] Antoni van Leeuwenhoek, Het Nederlands Kanker Inst, NKI AVL, Dept Pathol, Amsterdam, Netherlands

[6] ICORG, Dept Clin Res, Dublin, Ireland

[7] RCSI, Dept Physiol & Med Phys, Dublin, Ireland

[8] Univ Klinikum Mannheim, Dept Med 2, Mannheim, Germany

[9] OncoMark Ltd, Dept Res & Dev, Dublin, Ireland

[10] Univ Coll Dublin, Conway Inst, Dublin, Ireland

[11] KU Leuven VIB, Vesalius Res Ctr, Leuven, Belgium

来源：

EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷

关键词：

D O I：

10.1016/S0959-8049(16)32666-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S29 / S29

页数：1

共 50 条

[1] Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab
van Dijk, Erik
Biesma, Hedde D.
Cordes, Martijn
Smeets, Dominiek
Neerincx, Maarten
Das, Sudipto
Eijk, Paul P.
Murphy, Verena
Barat, Anna
Bacon, Orna
Prehn, Jochen H. M.
Betge, Johannes
Gaiser, Timo
Fender, Bozena
Meijer, Gerrit A.
McNamara, Deborah A.
Klinger, Rut
Koopman, Miriam
Ebert, Matthias P. A.
Kay, Elaine W.
Hennessey, Bryan T.
Verheul, Henk M. W.
Gallagher, William M.
O'Connor, Darran P.
Punt, Cornelis J. A.
Loupakis, Fotios
Lambrechts, Diether
Byrne, Annette T.
van Grieken, Nicole C. T.
Ylstra, Bauke
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) : 2052 - +
[2] Loss of chromosome 18q11.2-18q12.1 is predictive for progression-free survival in metastatic colorectal cancer patients treated with bevacizumab
van Dijk, Erik
Biesma, Hedde
Cordes, Martijn
Smeets, Dominiek
Neerincx, Maarten
Das, Sudipto
Murphy, Verena
Barat, Anna
Bacon, Orna
Prehn, Jochen H. M.
Betge, Johannes
Timo, Gaiser
Fender, Bozena
Meijer, Gerrit A.
McNamara, Deborah A.
Klinger, Rut
Koopman, Miriam
Ebert, Matthias P. A.
Kay, Elaina W.
Hennessey, Bryan T.
Verheul, Henk M. W.
Gallagher, William M.
O'Connor, Darran P.
Punt, Cornelis J. A.
Loupakis, Fotios
Lambrechts, Diether
Byrne, Annette
van Grieken, Nicole C. T.
Ylstra, Bauke
CANCER RESEARCH, 2018, 78 (13)
[3] Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX
van Dijk, Erik
van Werkhoven, Erik
Asher, Rebecca
Mooi, Jennifer K.
Espinoza, David
van Essen, Hendrik F.
van Tinteren, Harm
van Grieken, Nicole C. T.
Punt, Cornelis J. A.
Tebbutt, Niall C.
Ylstra, Bauke
INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (07) : 1166 - 1174
[4] Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
Takahashi, Toshiaki
Shigeyasu, Kunitoshi
Kondo, Yoshitaka
Takeda, Sho
Umeda, Hibiki
Moriwake, Kazuya
Kayano, Masashi
Sakurai, Yuya
Nakamura, Shunsuke
Takahashi, Masafumi
Nitta, Kaori
Yoshida, Kazuhiro
Matsumi, Yuki
Michiue, Hiroyuki
Yamamoto, Hideki
Kishimoto, Hiroyuki
Teraishi, Fuminori
Shoji, Ryohei
Kanaya, Nobuhiko
Kashima, Hajime
Kakiuchi, Yoshihiko
Kuroda, Shinji
Kagawa, Shunsuke
Fujiwara, Toshiyoshi
BMC CANCER, 2025, 25 (01)
[5] Visceral fat as a predictive marker of response to bevacizumab -based treatment in metastatic colorectal cancer.
Miyamoto, Yuji
Sakamoto, Yasuo
Watanabe, Masayuki
Baba, Hideo
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[6] Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer
Martínez-López, E
Abad, A
Font, A
Monzó, M
Ojanguren, I
Pifarré, A
Sánchez, JJ
Martín, C
Rosell, R
GASTROENTEROLOGY, 1998, 114 (06) : 1180 - 1187
[7] Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2
Thorsten Thye
Fredrik O Vannberg
Sunny H Wong
Ellis Owusu-Dabo
Ivy Osei
John Gyapong
Giorgio Sirugo
Fatou Sisay-Joof
Anthony Enimil
Margaret A Chinbuah
Sian Floyd
David K Warndorff
Lifted Sichali
Simon Malema
Amelia C Crampin
Bagrey Ngwira
Yik Y Teo
Kerrin Small
Kirk Rockett
Dominic Kwiatkowski
Paul E Fine
Philip C Hill
Melanie Newport
Christian Lienhardt
Richard A Adegbola
Tumani Corrah
Andreas Ziegler
Andrew P Morris
Christian G Meyer
Rolf D Horstmann
Adrian V S Hill
Nature Genetics, 2010, 42 : 739 - 741
[8] Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients
De Stefano, Alfonso
Carlomagno, Chiara
Pepe, Stefano
Bianco, Roberto
De Placido, Sabino
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) : 1207 - 1213
[9] Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients
Alfonso De Stefano
Chiara Carlomagno
Stefano Pepe
Roberto Bianco
Sabino De Placido
Cancer Chemotherapy and Pharmacology, 2011, 68 : 1207 - 1213
[10] Low Visceral Fat Content Is a Negative Predictive Marker for Bevacizumab in Metastatic Colorectal Cancer
Miyamoto, Yuji
Oki, Eiji
Emi, Yasunori
Tokunaga, Shoji
Shimokawa, Mototsugu
Ogata, Yutaka
Akagi, Yoshito
Sakamoto, Yasuo
Tanaka, Takaho
Saeki, Hiroshi
Maehara, Yoshihiko
Baba, Hideo
ANTICANCER RESEARCH, 2018, 38 (01) : 491 - 499

← 1 2 3 4 5 →